Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th
05 Setembro 2023 - 10:00AM
Artelo Biosciences, Inc. (Nasdaq: ARTL), a
clinical-stage pharmaceutical company focused on modulating
lipid-signaling pathways to develop treatments for people living
with cancer, pain, and neurological conditions, today announced
that it will be participating in the H.C. Wainwright 25th Annual
Global Investment Conference being held September 11-13, 2023 at
the Lotte New York Palace Hotel in New York City.
Gregory Gorgas, CEO of Artelo Biosciences, is
scheduled to present on September 13, 2023 at 2:00 PM Eastern Time.
The presentation will be webcast live on the conference event
platform, which can be accessed at
https://journey.ct.events/view/a3fb36ce-8e0f-41c1-b530-feebded86361 and
on the investor relations section of Artelo’s website at
https://ir.artelobio.com/.
Management will be participating in one-on-one
meetings with qualified members of the investor community
throughout the conference in New York City. To request a meeting,
please contact ARTL@crescendo-ir.com.
About Artelo BiosciencesArtelo
Biosciences, Inc. is a clinical stage pharmaceutical company
dedicated to the development and commercialization of proprietary
therapeutics that modulate lipid-signaling pathways including the
endocannabinoid system. Artelo is advancing a portfolio of broadly
applicable product candidates designed to address significant unmet
needs in multiple diseases and conditions, including anorexia,
cancer, anxiety, pain, neuropathy, and inflammation. Led by proven
biopharmaceutical executives collaborating with highly respected
researchers and technology experts, the company applies leading
edge scientific, regulatory, and commercial discipline to develop
high-impact therapies. More information is available
at www.artelobio.com and Twitter: @ArteloBio.
Investor Relations
Contact:Crescendo Communications, LLCTel:
212-671-1020Email: ARTL@crescendo-ir.com
Artelo Biosciences (NASDAQ:ARTL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Artelo Biosciences (NASDAQ:ARTL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024